These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14593960)

  • 1. [The results of conservative treatment of oxalate urolithiasis in children].
    Rogowska-Kalisz A; Tkaczyk M; Bilińska W; Nowicki M
    Pol Merkur Lekarski; 2003 Jul; 15(85):51-4. PubMed ID: 14593960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy).
    De Santo NG; Di Iorio B; Capasso G; Paduano C; Stamler R; Langman CB; Stamler J
    Pediatr Nephrol; 1992 Mar; 6(2):149-57. PubMed ID: 1571211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction of urinary oxalate excretion by administration of calcium and citrate].
    Ito H; Yamaguchi K; Nishikawa Y; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1417-21. PubMed ID: 2601215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
    Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
    Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
    Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
    Siener R; Ebert D; Nicolay C; Hesse A
    Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of oxalate urolithiasis with alkaline citrates.
    Frang D; Berényi M; Szebeni R
    Ther Hung; 1990; 38(2):64-70. PubMed ID: 2377983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.